<html>
<head>PUBMED IDs for TROY</head>
<body bgcolor='#C5F0F2'><h1>TROY</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10764796/'>TROY, a newly identified member of the tumor necrosis factor receptor superfamily, exhibits a homology with Edar and is expressed in embryonic skin and hair follicles.</a> April 15  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12763585/'>Expression of a member of tumor necrosis factor receptor superfamily, TROY, in the developing mouse brain.</a> May 24  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14699584/'>Traf6 is essential for murine tooth cusp morphogenesis.</a> December 31  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15020679/'>An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression.</a> March 17  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17187358/'>Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target.</a> December 26  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18584774/'>TROY, a novel member of the tumor necrosis factor receptor superfamily in the central nervous system.</a> June 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18584566/'>Pharmacogenetic treatments for drug addiction: alcohol and opiates.</a> June 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20881009/'>TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling.</a> February 18  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20881004/'>Association of aromatase (TTTAn) repeat polymorphism length and the relationship between obesity and decreased sperm concentration.</a> March 25  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21059749/'>Emerging functions of myelin-associated proteins during development, neuronal plasticity, and neurodegeneration.</a> April 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21059738/'>C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach.</a> April 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21059727/'>Ethics of mitochondrial gene replacement: from bench to bedside.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22057614/'>Tumor necrosis factor-receptor 2 and TROY gene expression patterns in cutaneous squamous cell carcinoma in a Tunisian population.</a> February 22  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22710967/'>Expression of the Nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.</a> September 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23699535/'>TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.</a> April 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26071990/'>Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats.</a> April 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26071969/'>Combined hypoxia inducible factor-1Î± and homogeneous endothelial progenitor cell therapy attenuates shunt flow-induced pulmonary arterial hypertension in rabbits.</a> February 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26559543/'>Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.</a> November 2  2015<br></body></html>
